KVUE
Kenvue Inc.
NYSE · Consumer Defensive · Household & Personal Products · US
$18.87
−0.21%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$18.70
From 52W high−4.84%
Volume13.70M
Market cap$36.24B
P/E (TTM)21.7x
P/S (TTM)2.4x
Div yield5.52%
Key dataOct 19, 2026
Open
$18.70
From 52W high
−4.84%
Volume
13.70M
Market cap
$36.24B
ValuationView details →
P/E (Fwd)
15.5x
EV/EBITDA
13.8x
P/E (TTM)
21.7x
RSI (14)
63.9
MomentumView details →
1D Return
−0.21%
YTD Return
+8.72%
SummaryUpdated Jun 1, 2026
Kenvue Inc. (NYSE:KVUE) is a consumer health company that emerged as an independent entity in May 2023 following its spin-off from Johnson & Johnson. Founded in 2022 and headquartered in Skillman, New Jersey, Kenvue operates as one of the world's largest pure-play consumer health companies, managing a portfolio of trusted household brands that have been part of families' daily routines for decades. The company went public through an initial public offering in May 2023, marking its transition from being a subsidiary of J&J to a standalone publicly traded corporation focused exclusively on consumer health products.
Similar companies
Latest newsMore news →
KIMBERLY CLARK CORP is selling investment-grade bonds in as many as five parts to help fund its pending acquisition of Kenvue Inc..13h agoKimberly-Clark held investor calls ahead of a possible bond sale to support its pending acquisition of Kenvue.3d agoSunscreens containing bemotrizinol began arriving on U.S. store shelves, including products from Kenvue Inc. and other manufacturers.5d ago